Jasper Hellweg's Stock Ratings

Argus Research Analyst

Jasper Hellweg is an analyst at Argus Research. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 09/06/2024

Overall Average Return

6.83%

Smart Score

62.9%

Overall Average Return Percentile

53rd

Number of Ratings

30
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

What Analysts Are Saying About Regeneron Pharmaceuticals Stock
Analyst Ratings For Regeneron Pharmaceuticals
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
The Analyst Landscape: 14 Takes On Regeneron Pharmaceuticals
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
13 Analysts Have This To Say About Vertex Pharmaceuticals
Assessing Novo Nordisk: Insights From 10 Financial Analysts
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
Although US stocks closed mixed on Thursday, but healthcare stocks recorded gains, gaining over 0.2% in the previous session. Biotechnology stocks were among the top performers in the sector, adding around 0.5% on Thursday.
Why Moderna Shares Are Rising Today
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 7.08% to $140.52 Wednesday afternoon. The company said it is open to providing COVID vaccines to China and building a COVID vaccine plant in Japan. What Happened?
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free